Your browser doesn't support javascript.
loading
Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia.
Witty, David R; Alvaro, Giuseppe; Derjean, Dominique; Giblin, Gerard M P; Gunn, Kevin; Large, Charles; Macpherson, David T; Morisset, Valerie; Owen, Davina; Palmer, Joanne; Rugiero, Francois; Tate, Simon; Hinckley, Christopher A; Naik, Himanshu.
Afiliación
  • Witty DR; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Alvaro G; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Derjean D; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Giblin GMP; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Gunn K; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Large C; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Macpherson DT; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Morisset V; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Owen D; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Palmer J; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Rugiero F; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Tate S; Convergence Pharmaceuticals Ltd., a Biogen Company, Babraham Research Campus, Cambridge CB22 3AT, U.K.
  • Hinckley CA; Biogen Inc., 225 Binney Street, Cambridge, Massachusetts 02142, United States.
  • Naik H; Biogen Inc., 225 Binney Street, Cambridge, Massachusetts 02142, United States.
ACS Med Chem Lett ; 11(9): 1678-1687, 2020 Sep 10.
Article en En | MEDLINE | ID: mdl-32945812

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido